Viracta Therapeutics Inc
Biotechnology
Healthcare
VIRX
38.56 M shares
NASDAQ US
traded
13 Sep 2023
listed
yes
open
1.30
52 week high
5.69
high
1.36
52 week low
1.32
previous Close
1.36
P/E ratio
market cap
49.93 M
div yield
0
net incoming
-12.48 M
-2.25 %
net profit margin
-1248400000.00 %
0.00 %
operating incoming
-12.45 M
-1.99 %
net change in cash
0.00 %
cash on hand
14.29 M
-21.03 %
top